当前位置: X-MOL 学术Antivir. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s.
Antiviral Therapy ( IF 1.3 ) Pub Date : 2017-11-25 , DOI: 10.3851/imp3209
Charles S Venuto 1, 2 , Jihoon Lim 1 , Susan Messing 3 , Peter W Hunt 4 , Grace A McComsey 5 , Gene D Morse 2
Affiliation  

Inflammation is associated with the downregulation of drug metabolizing enzymes and transporters. Thus, we investigated the chronic inflammatory state associated with HIV infection as a source of pharmacokinetic variability of atazanavir. We also explored the association of total bilirubin concentrations with markers of inflammation and endothelial activation.

中文翻译:


在艾滋病临床试验组方案 A5224 中,炎症被作为阿扎那韦药代动力学变异的一个来源进行了研究。



炎症与药物代谢酶和转运蛋白的下调有关。因此,我们研究了与 HIV 感染相关的慢性炎症状态,作为阿扎那韦药代动力学变异的来源。我们还探讨了总胆红素浓度与炎症和内皮激活标志物的关系。
更新日期:2020-08-21
down
wechat
bug